Source: PR-INSIDE.COM

Press Release: MacuCLEAR : Just Published: "MacuCLEAR, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile"

(PR-inside.com) MacuCLEAR, Inc. (MacuCLEAR) is an eye care product company. The company develops and offers eye drops. Its products include MC-1101 and MC-4001. MacuCLEAR's MC-1101 is an oral anti-hypertensive drug, which is used in the treatment of dry age related macular degeneration. The company's MC-1101 modulates choroidal blood flow humans and reduces inflammation and oxidative stress. Its MC-4001 is an interluekin-1inhibitor to treat diabetic diseases of the eye. The company offers products for treatment of diabetic retinopathy and other retinal diseases. It partners with other companies for preclinical, clinical and regulatory activities. MacuCLEAR is headquartered in Plano, Texas, the US. MacuCLEAR, Inc. ..

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
BB Tuley's photo - CEO of MacuCLEAR

CEO

BB Tuley

CEO Approval Rating

81/100

Read more